This is a registered report describing a planned crossover study that will test whether wearing an FFP2 face mask affects walking adaptability in 50 patients with Parkinson's disease or Multiple Sclerosis undergoing inpatient neurorehabilitation.
PLOS ONE · 6 authors, 7 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This is a registered report describing a planned crossover study that will test whether wearing an FFP2 face mask affects walking adaptability in 50 patients with Parkinson's disease or Multiple Sclerosis undergoing inpatient neurorehabilitation.
This registered report outlines a planned crossover study investigating the effects of FFP2 face-mask wearing on walking adaptability in patients with Parkinson's disease or Multiple Sclerosis during inpatient neurorehabilitation. Fifty patients will be randomized to perform the C-Gait test on a VR-based C-Mill+VR treadmill and four clinical mobility tests with and without an FFP2 mask. The primary endpoint is the C-Gait composite score, calculated as the mean of high-difficulty subtests plus the cognitive dual-task score. Secondary endpoints include the seven C-Gait subtest scores, the 10-Meter Walk test, the Timed Up-and-Go test with and without a dual task, and stair ascent/descent. Participants will also report perceived performance and safety. As a registered report, no results are yet available; the protocol is registered as DRKS00030207 with planned data collection from 12/2022 to 7/2023, and ethical approval was granted by the University of Bonn Ethics Committee (269/21).